| PAGE-B predicts the risk of developing hepatocellular carcinoma in Caucasians with chronic hepatitis B on 5-year antiviral therapy G Papatheodoridis, G Dalekos, V Sypsa, C Yurdaydin, M Buti, J Goulis, ... Journal of hepatology 64 (4), 800-806, 2016 | 172 | 2016 |
| Mycophenolate for the treatment of autoimmune hepatitis: prospective assessment of its efficacy and safety for induction and maintenance of remission in a large cohort of … K Zachou, N Gatselis, G Papadamou, EI Rigopoulou, GN Dalekos Journal of hepatology 55 (3), 636-646, 2011 | 162 | 2011 |
| autoimmune hepatitis–current management and challenges K Zachou, P Muratori, GK Koukoulis, A Granito, N Gatselis, A Fabbri, ... Alimentary pharmacology & therapeutics 38 (8), 887-913, 2013 | 160 | 2013 |
| The risk of hepatocellular carcinoma decreases after the first 5 years of entecavir or tenofovir in Caucasians with chronic hepatitis B GV Papatheodoridis, R Idilman, GN Dalekos, M Buti, H Chi, ... Hepatology 66 (5), 1444-1453, 2017 | 159 | 2017 |
| Adipokines as mediators of endothelial function and atherosclerosis G Ntaios, NK Gatselis, K Makaritsis, GN Dalekos Atherosclerosis 227 (2), 216-221, 2013 | 154 | 2013 |
| Autoantibodies and defined target autoantigens in autoimmune hepatitis: an overview GN Dalekos, K Zachou, C Liaskos, N Gatselis European journal of internal medicine 13 (5), 293-303, 2002 | 152 | 2002 |
| Autoimmune hepatitis, one disease with many faces: etiopathogenetic, clinico-laboratory and histological characteristics NK Gatselis, K Zachou, GK Koukoulis, GN Dalekos World journal of gastroenterology: WJG 21 (1), 60, 2015 | 141 | 2015 |
| Clostridium difficile and inflammatory bowel disease: role in pathogenesis and implications in treatment O Nitzan, M Elias, B Chazan, R Raz, W Saliba World journal of gastroenterology: WJG 19 (43), 7577, 2013 | 134* | 2013 |
| Incidence and predictors of hepatocellular carcinoma in Caucasian chronic hepatitis B patients receiving entecavir or tenofovir GV Papatheodoridis, GN Dalekos, C Yurdaydin, M Buti, J Goulis, ... Journal of hepatology 62 (2), 363-370, 2015 | 129 | 2015 |
| Anti‐cardiolipin antibodies in patients with chronic viral hepatitis are independent of beta2‐glycoprotein I cofactor or features of antiphospholipid syndrome K Zachou, C Liaskos, DK Christodoulou, M Kardasi, G Papadamou, ... European journal of clinical investigation 33 (2), 161-168, 2003 | 92 | 2003 |
| Comparison of simplified score with the revised original score for the diagnosis of autoimmune hepatitis: a new or a complementary diagnostic score? NK Gatselis, K Zachou, P Papamichalis, GK Koukoulis, S Gabeta, ... Digestive and Liver Disease 42 (11), 807-812, 2010 | 78 | 2010 |
| Spontaneous spondylodiscitis: presentation, risk factors, diagnosis, management, and outcome E Kapsalaki, N Gatselis, A Stefos, K Makaritsis, A Vassiou, I Fezoulidis, ... International Journal of Infectious Diseases 13 (5), 564-569, 2009 | 78 | 2009 |
| Dried-leaf Artemisia annua: A practical malaria therapeutic for developing countries? PJ Weathers, M Towler, A Hassanali, P Lutgen, PO Engeu World journal of pharmacology 3 (4), 39, 2014 | 75* | 2014 |
| Presence of high avidity anticardiolipin antibodies in patients with autoimmune cholestatic liver diseases K Zachou, C Liaskos, E Rigopoulou, S Gabeta, P Papamichalis, ... Clinical Immunology 119 (2), 203-212, 2006 | 69 | 2006 |
| A real‐world study focused on the long‐term efficacy of mycophenolate mofetil as first‐line treatment of autoimmune hepatitis K Zachou, NK Gatselis, P Arvaniti, S Gabeta, EI Rigopoulou, ... Alimentary pharmacology & therapeutics 43 (10), 1035-1047, 2016 | 65 | 2016 |
| Prevalence and clinical significance of anticardiolipin antibodies in patients with type 1 autoimmune hepatitis C Liaskos, E Rigopoulou, K Zachou, S Georgiadou, N Gatselis, ... Journal of autoimmunity 24 (3), 251-260, 2005 | 59 | 2005 |
| Adiponectin: a key playmaker adipocytokine in non-alcoholic fatty liver disease NK Gatselis, G Ntaios, K Makaritsis, GN Dalekos Clinical and experimental medicine 14 (2), 121-131, 2014 | 55 | 2014 |
| Clinical significance of organ‐and non‐organ‐specific autoantibodies on the response to anti‐viral treatment of patients with chronic hepatitis C NK Gatselis, SP Georgiadou, GK Koukoulis, N Tassopoulos, K Zachou, ... Alimentary pharmacology & therapeutics 24 (11‐12), 1563-1573, 2006 | 55 | 2006 |
| Kinetics of circulating immunoglobulin M in sepsis: relationship with final outcome EJ Giamarellos-Bourboulis, E Apostolidou, M Lada, I Perdios, NK Gatselis, ... Critical Care 17 (5), 1-9, 2013 | 54 | 2013 |
| Clinical significance of the fluctuation of primary biliary cirrhosis-related autoantibodies during the course of the disease NK Gatselis, K Zachou, GL Norman, S Gabeta, P Papamichalis, ... Autoimmunity 46 (7), 471-479, 2013 | 49 | 2013 |
